133 related articles for article (PubMed ID: 35570050)
1. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
[TBL] [Abstract][Full Text] [Related]
2. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
3. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer.
Bhatnagar A; Loper A
Radiat Oncol; 2010 Sep; 5():87. PubMed ID: 20875139
[TBL] [Abstract][Full Text] [Related]
4. Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer.
Ota K; Adar T; Dover L; Khachemoune A
J Dermatolog Treat; 2018 Mar; 29(2):170-175. PubMed ID: 28604229
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
6. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
7. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
Bhatnagar A
Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
[TBL] [Abstract][Full Text] [Related]
8. Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study.
Patel R; Strimling R; Doggett S; Willoughby M; Miller K; Dardick L; Mafong E
J Contemp Brachytherapy; 2017 Aug; 9(4):338-344. PubMed ID: 28951753
[TBL] [Abstract][Full Text] [Related]
9. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
10. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
[TBL] [Abstract][Full Text] [Related]
12. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
[TBL] [Abstract][Full Text] [Related]
13. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer.
Lancellotta V; Kovács G; Tagliaferri L; Perrucci E; Rembielak A; Stingeni L; Tramontana M; Hansel K; Colloca G; Saldi S; Valentini V; Aristei C
J Geriatr Oncol; 2019 May; 10(3):514-517. PubMed ID: 30314955
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer.
Pellizzon ACA; Fogaroli R; Chen MJ; Maia P; Gondim G; Guedes DC; Ramos H; Silva MLG
J Contemp Brachytherapy; 2020 Oct; 12(5):435-440. PubMed ID: 33299432
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique.
Brovchuk S; Park SJ; Shepil Z; Romanenko S; Vaskevych O
J Contemp Brachytherapy; 2022 Apr; 14(2):107-114. PubMed ID: 35494184
[TBL] [Abstract][Full Text] [Related]
16. High dose brachytherapy with non sealed
Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1511-1521. PubMed ID: 33140131
[TBL] [Abstract][Full Text] [Related]
17. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer.
Montero A; Hernanz R; Capuz AB; Fernández E; Hervás A; Colmenares R; Polo A; Sancho S; Molerón R; Vallejo C; Ramos A
Clin Transl Oncol; 2009 Nov; 11(11):760-4. PubMed ID: 19917540
[TBL] [Abstract][Full Text] [Related]
19. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
[TBL] [Abstract][Full Text] [Related]
20. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]